|
37 |
Additional Guidance on the Submission of Master listing and Line Listing in the Vaccine Information Mangement System (VIMS) |
May 11, 2021 |
|
38 |
Further Guidance on the Administration of AstraZeneca Vaccines from the COVAX Facility Amending Advisory No. 36 dated 9 May 2021 |
May 11, 2021 |
|
39 |
Guidance on the Vaccination Roll-out of Pfizer Vaccines from COVAX Facility |
May 21, 2021 |
|
39 |
Annex A: Vaccine Preparation and Administration Workflow Tool |
May 21, 2021 |
|
40 |
Inclusion of Local Chief Executives in Priority A1: Workers in Frontline Health Services |
May 15, 2021 |
|
41 |
Reiteration on the Scheduling for Vaccination of Individuals with COVID-19 Infection |
May 15, 2021 |
|
42 |
Additional Guidance on COVID-19 Vaccine Storage, Handling and Distribution |
May 14, 2021 |
|
43 |
Guidance for Government Agencies to Prepare Masterlist of Employees Covered by the National COVID-19 Vaccine Deployment and Vaccination Program Prioritization Framework |
May 15, 2021 |
|
43 |
Masterlisting Template |
May 15, 2021 |
|
44 |
Reiteration on the Guidance on Blood Pressure Taking and Medical Clearance Requirements |
May 18, 2021 |
|
45 |
Reiteration of Specific Department of Health Policies on the COVID-19 Vaccination Process |
May 21, 2021 |
|
46 |
Advisory on Submission of Line List Forms and Report of Health Screening |
May 26, 2021 |
